In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
about
The Role of Hedgehog Signaling in Tumor Induced Bone DiseaseCooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapyMolecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cellsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue XenograftsCoordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.Molecular profiling of childhood cancer: Biomarkers and novel therapiesBiological and clinical implications of cancer stem cells in primary brain tumors.Cancer stem cell theory: therapeutic implications for nanomedicine.Toward a systems-level understanding of the Hedgehog signaling pathway: defining the complex, robust, and fragile.Hedgehog pathway inhibitors: a patent review (2009--present).Enhancing radiation therapy for patients with glioblastoma.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.Strategies to target the Hedgehog signaling pathway for cancer therapy.Translational gap in ongoing clinical trials for glioma.Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.Hedgehog signalling pathway inhibitors as cancer suppressing agents
P2860
Q26783615-CC5B2DED-43DB-45F3-8047-1E9BB700BCB4Q26865136-74C4AAAC-5666-4B3B-8AB0-70CCCD75F888Q28081405-D3D11378-9793-49E2-92E8-271AF4E3F744Q28081844-80C3B758-B2E7-46DF-805D-81D7F83054F1Q28534130-DACC2D7B-9DF5-45A8-B0FA-7161FDDFC67BQ34374039-7C046CEE-1BAF-4830-9E73-4B4BED947CD8Q35551899-D482541C-D31A-4C87-8021-17100A67D462Q36250783-AD0FA019-964E-4419-B7E4-4F238228822AQ36562573-85FB677A-CF4F-42C4-9182-58B46C2E1E8EQ36659443-C1602ED5-5566-44A1-80B7-FC0E34FC3F33Q38051564-772043DB-E599-4A6A-84B5-5A4A9EBD26FEQ38072095-85E7C5F9-C13E-4038-85CC-838288D55C26Q38101608-5B725495-282A-4DEB-9DE5-289FC93B5EA3Q38233171-BA849B7D-F4A9-4351-BE4A-8E636AC31D18Q42335701-222A7C2D-8BE6-4B56-93DB-9135CC7E1F18Q47218042-E9E9A132-635C-4777-AFA1-2085FF37C831Q48002716-3AD52CE4-BDE7-4176-A1E0-90923FC55D38Q49511494-3BF05026-73FD-47D8-93ED-FA40DAE3BCFAQ57905193-97BE3872-0B45-4B8D-95C1-5ACD018371C6
P2860
In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
In vitro and in vivo character ...... human glioblastoma cell lines.
@en
In vitro and in vivo character ...... human glioblastoma cell lines.
@nl
type
label
In vitro and in vivo character ...... human glioblastoma cell lines.
@en
In vitro and in vivo character ...... human glioblastoma cell lines.
@nl
prefLabel
In vitro and in vivo character ...... human glioblastoma cell lines.
@en
In vitro and in vivo character ...... human glioblastoma cell lines.
@nl
P2093
P2860
P356
P1476
In vitro and in vivo character ...... human glioblastoma cell lines
@en
P2093
Antonella De Rosa
Cinzia Giordano
Elisa Mori
Federica Mennillo
Gal la Pericot Mohr
Giovanni Benedetti
Letizia Magnoni
Marco Rossi
Patrizia Tunici
Pietro Ferruzzi
P2860
P304
P356
10.1002/IJC.27349
P577
2012-01-31T00:00:00Z